Extraneurological sparing in long-lived typical Lafora disease

Danielle Goldsmith, Berge Arakel Minassian

Research output: Contribution to journalArticle

Abstract

Lafora disease (LD) clinically appears in previously healthy teenagers as progressively worsening seizures, myoclonus, dementia, and ultimately a vegetative state leading to death within a decade of its onset. Here we present a typical case of LD in which the patient survived until the age of 40. Although the patient's brain was severely affected, other organs remained functional until her death. The field of LD research is approaching potentially curative therapies (eg, with antisense oligonucleotides or gene replacement) targeting only the central nervous system (CNS). Our case provides anecdotal evidence suggesting that a patient with typical LD can retain full bodily health aside from the effects of neurological damage.

Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalEpilepsia Open
Volume3
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Lafora Disease
Persistent Vegetative State
Myoclonus
Gene Targeting
Antisense Oligonucleotides
Dementia
Seizures
Central Nervous System
Health
Brain
Research

Keywords

  • Adult polyglucosan disease
  • Epilepsy
  • Gene therapy
  • Lafora disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Extraneurological sparing in long-lived typical Lafora disease. / Goldsmith, Danielle; Minassian, Berge Arakel.

In: Epilepsia Open, Vol. 3, No. 2, 01.01.2018, p. 295-298.

Research output: Contribution to journalArticle

@article{7c8891bef91e4fec934d197f215f065f,
title = "Extraneurological sparing in long-lived typical Lafora disease",
abstract = "Lafora disease (LD) clinically appears in previously healthy teenagers as progressively worsening seizures, myoclonus, dementia, and ultimately a vegetative state leading to death within a decade of its onset. Here we present a typical case of LD in which the patient survived until the age of 40. Although the patient's brain was severely affected, other organs remained functional until her death. The field of LD research is approaching potentially curative therapies (eg, with antisense oligonucleotides or gene replacement) targeting only the central nervous system (CNS). Our case provides anecdotal evidence suggesting that a patient with typical LD can retain full bodily health aside from the effects of neurological damage.",
keywords = "Adult polyglucosan disease, Epilepsy, Gene therapy, Lafora disease",
author = "Danielle Goldsmith and Minassian, {Berge Arakel}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/epi4.12224",
language = "English (US)",
volume = "3",
pages = "295--298",
journal = "Epilepsia Open",
issn = "2470-9239",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Extraneurological sparing in long-lived typical Lafora disease

AU - Goldsmith, Danielle

AU - Minassian, Berge Arakel

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Lafora disease (LD) clinically appears in previously healthy teenagers as progressively worsening seizures, myoclonus, dementia, and ultimately a vegetative state leading to death within a decade of its onset. Here we present a typical case of LD in which the patient survived until the age of 40. Although the patient's brain was severely affected, other organs remained functional until her death. The field of LD research is approaching potentially curative therapies (eg, with antisense oligonucleotides or gene replacement) targeting only the central nervous system (CNS). Our case provides anecdotal evidence suggesting that a patient with typical LD can retain full bodily health aside from the effects of neurological damage.

AB - Lafora disease (LD) clinically appears in previously healthy teenagers as progressively worsening seizures, myoclonus, dementia, and ultimately a vegetative state leading to death within a decade of its onset. Here we present a typical case of LD in which the patient survived until the age of 40. Although the patient's brain was severely affected, other organs remained functional until her death. The field of LD research is approaching potentially curative therapies (eg, with antisense oligonucleotides or gene replacement) targeting only the central nervous system (CNS). Our case provides anecdotal evidence suggesting that a patient with typical LD can retain full bodily health aside from the effects of neurological damage.

KW - Adult polyglucosan disease

KW - Epilepsy

KW - Gene therapy

KW - Lafora disease

UR - http://www.scopus.com/inward/record.url?scp=85063925721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063925721&partnerID=8YFLogxK

U2 - 10.1002/epi4.12224

DO - 10.1002/epi4.12224

M3 - Article

C2 - 29881811

AN - SCOPUS:85063925721

VL - 3

SP - 295

EP - 298

JO - Epilepsia Open

JF - Epilepsia Open

SN - 2470-9239

IS - 2

ER -